1.
Maleki A, Colombo A, Look-Why S, Chang P, Anesi S, Foster CS. Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy. JOVR [Internet]. 2022Nov.24 [cited 2024Apr.25];17(4):515–528. Available from: https://knepublishing.com/index.php/JOVR/article/view/12304